Arena Events Group
Arena Events Group plc is global turnkey event solutions provider, supplying temporary physical structures, seating, exhibition services, refrigeration, barriers & fencing, ice rinks, furniture, and interiors for some of the most prestigious events across the UK & Europe, the Americas, and the Middle East and Asia. Clients include Wimbledon Tennis, The Open, PGA European Tour, Ryder Cup, IMG, Google, and Frieze Art Fair.
Arena services major sporting, outdoor and leisure events, providing a managed solution from concept and design through to the construction and integration of the final structure and interior. Contracts range in size and complexity from a simple equipment rental for a local outdoor event, to an integrated solution of multiple structures and interiors for a major international sporting event.
CloudCall provide Unified Communications solutions that tightly integrate with CRM systems, allowing businesses to log all their communications including Voice, Text and Instant Messaging. By linking the customer data held in the CRM with communication software, businesses can use the critical insight and intelligence provided to make decisions faster and undertake more targeted and accurate interactions to increase productivity and drive business performance.
Creo Medical is a medical device company focused on the emerging field of surgical endoscopy, a recent development in minimally invasive surgery. The company’s mission is to improve patient outcomes by applying microwave and radiowave energy to surgical endoscopy.
Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.
Creo has developed CROMA, an electrosurgical platform that can deliver microwave and bipolar radiofrequency through a single accessory port. This technology makes it possible to conduct endoscopic surgery by enabling miniature endoscopic devices to cut, coagulate and ablate with precision.
The company’s strategy is to bring the CROMA platform to market through a suite of medical instruments which the company has designed, initially into the field of GI therapeutic endoscopy, and later into a broader range of areas including bronchoscopy and laparoscopy.
The Company completed the development required to gain CE Mark accreditation for the CROMA platform and Speedboat in Europe in 2017. Following this and six months ahead of management's expectations, the Company received 510(k) clearance from the FDA for its CROMA platform and Speedboat in August 2017.
Creo Medical listed on the AIM market of the London Stock Exchange on 9 December 2016, under the name “Creo Medical Group plc”.
Diaceutics is the leading data analytics and implementation service provider in the diagnostic commercialization industry.
Sourcing data from over 2500 clinical laboratories around the world, Diaceutics provides an end to end service to biopharmaceutical companies encompassing everything from understanding the diagnostic landscape to test implementation into treatment pathways.
Their ultimate goal is to drive better testing to enable better treatment decisions for patients.
AIM-listed Duke Royalty is a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. The company, which is bringing royalty finance to UK and European businesses outside of the mining sector for the first time, has a market capitalisation of more than £87m and has one of the junior market’s highest yielding dividends.
FairFX is a leading challenger brand in banking and payments that provides banking and payment services to both personal and business customers through Current Accounts, Currency Cards, Travel Cash, International Money Transfers, and a Corporate Card and Expense Platform. FairFX has been helping customers get more since 2007 and continue to serve over 1 million customers.
Gresham House Strategic plc invests primarily in UK and European smaller public companies, applying private equity techniques and due diligence alongside a value investment philosophy to construct a focused portfolio expected to be comprised of 10-15 companies.
The Investment Manager aims for a considerably higher level of engagement with investee company stakeholders, including management, shareholders, customers, suppliers and competitors, with the aim of identifying market pricing inefficiencies and supporting a clear equity value creation plan and targeting above market returns over the longer-term.
Hardide is the leading global innovator and provider of advanced tungsten carbide coatings that significantly increase the working life of critical metal components operating in abrasive, erosive, corrosive and chemically aggressive environments. Our coatings are value-adding to components and lower operational costs by reducing downtime, increasing productivity and improving performance. They can be applied to external and internal surfaces including complex geometries, enabling a level of engineering design flexibility not possible with alternative technologies.
Immotion is focused on the delivery of truly immersive “out of home” Virtual Reality experiences through the combination of award winning VR content, and cutting-edge motion platform technology. It has three channels to market, each one solving a problem.
- Concession Partners – Delivering valuable ancillary revenue to high footfall leisure destinations. Partners include Merlin, Rank, Gravity Trampoline Parks to name but a few.
- Owned and franchised ImmoitonVR Experience Centres. – Bringing an entertainment destination to Shopping Malls.
- Sale of VR Motion Platforms – A range of operator-lite VR platforms, perfect for Family Entertainment Centres.
Jaywing plc is a data science-led agency and consulting business, with a marketing technology division and growing international footprint. The agency has two core propositions, performance marketing and brand-led marketing. Jaywing’s data science consultancy helps clients do smart things with their data in marketing, credit risk, and business intelligence. Jaywing Intelligence offers AI and big data led products. Jaywing employs over 450 people, 15% of which are experienced data scientists, and has offices in Sheffield, Leeds, London, Newbury and Sydney.
Manolete Partners Plc is a leading insolvency litigation financing company in the UK and was founded in 2009 by its CEO, Steven Cooklin. Manolete has invested in over 240 UK insolvency litigation cases and has completed over 170 of them. Manolete works alongside Insolvency Practitioners (IPs) from all of the “Big Four” to smaller regional firms. Manolete has worked with over 100 IP firms and their chosen legal advisers, often on multiple cases.
Manolete is different from other litigation funders because cases are completed very quickly – the average duration is less than 12 months. The large majority are settled long before trial - minimising costs and optimising returns. Recent legal changes (the Jackson Reforms and the Small Business Enterprise and Employment Act) have freed up the insolvency sector, making Manolete's bespoke financing solutions particularly well suited to the challenges of insolvency litigation.
Manolete was ranked in the Financial Times’ Europe’s Fastest Growing Companies 2018. The Company has been shortlisted for ‘Insolvency Litigation Funder of the Year’ at the Turnaround, Restructuring and Insolvency Industry Awards in each of the last three years and was the winner on two occasions. Manolete was listed on AIM on 14 December 2018.
Mercia Technologies (MERC)
Mercia is a national investment group focused on the funding and scaling of innovative technology businesses with high growth potential from the UK regions. Mercia benefits from 19 university partnerships and offices across the Midlands, the North of England and Scotland providing it with access to high quality, regional deal flow. Mercia Technologies PLC is quoted on AIM with the epic "MERC".
Mercia's 'Complete Capital Solution' initially nurtures businesses via its third-party funds (now with circa £400million under management) and then over time Mercia can provide further funding to the most promising companies by deploying direct investment follow-on capital from its own balance sheet. Since its IPO in December 2014, Mercia has invested over £69million across its direct investment portfolio.
Mirada is a leading provider of products and services for Digital TV Operators and Broadcasters. Founded in 2000 and led by CEO José Luis Vázquez, the company prides itself on having spent almost 20 years as a pioneer in the Digital TV market. Mirada's core focus is on the ever-growing demand for TV Everywhere for which it offers a complete suite of end-to-end modular products across multiple devices, all with innovative state-of-the-art UI designs.
Radient Technologies is an extraction solutions provider and manufacturer of high-value natural ingredients and products. Our patented, proprietary MAP™ extraction platform safely extracts active natural compounds from a wide range of biological materials at rapid speed, providing superior customer outcomes in terms of ingredient purity, yield, and cost. Headquartered in Edmonton, Alberta, and fast becoming a global company, we work closely with our clients every step of the way to help them develop the highest quality naturally derived products. Radient is fully GMP compliant, Health Canada approved, and NNHPD certified.
Seeing Machines is a world leader in driver-machine interaction. We harness human factors science to create artificial intelligence (AI) technology that observes the driver’s attention – reliably, unobtrusively, and in real time – and intervenes seamlessly when necessary.
Seeing Machines specialises in computer vision algorithms that precisely track eye gaze, head position and pupil size, and our state-of the-art AI technology analyses the data to quickly and accurately detect driver drowsiness, distraction and microsleep events.
Shield is a commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients' unmet medical needs. Our clear purpose is to help our patients become people again, by enabling them to enjoy the things that make the difference in their everyday lives. The Group has a marketed product, Feraccru®, for the treatment of iron deficiency in adult patients with or without anaemia. Feraccru® has exclusive IP rights until the mid-2030's.
Synnovia is a niche manufacturer of specialist products. Applications for these products vary widely and examples include:
• Packaging for the food manufacturing and distribution – films, sacks and pouches
• Steering columns and instrument control knobs in the automotive industry – plastic bearings
• Hydraulic and industrial rubber hose manufacture – various types of mandrel
• Cardboard box manufacture – creasing matrices
Synnovia’s business model is based on understanding customers’ problems in depth, and then developing and mass producing proprietary, technical solutions for these problems. As such many projects can take significant time to translate initial sale into volume production. The business operates through two divisions, Films and Industrial, and has the majority of its production in six UK based factories, with a further two factories in Asia and one in the USA. Approximately 50% of its £80 million sales, as per current run-rate, are made outside the UK to more than 80 countries.
Trackwise is a UK – based specialist manufacturer of products using printed circuit technology. The Company has historically served the telecommunications and wider radio frequency community with specialist PCBs.
However, a patented process innovation has extended Trackwises’ capability to the unique manufacture of length unlimited multilayer flexible PCBs. Marketed as Improved Harness Technology™, boards of such length can be used as a weight/space saving alternative to traditional wiring harnesses across high value, mass critical market sectors and applications.